Form 8-K SYNTEL INC For: Oct 16

Go back to Form 8-K SYNTEL INC For: Oct 16

Weakness in Healthcare is Buying Opportunity for Syntel (SYNT) - Noble Financial

October 17, 2014 11:19 AM EDT

Noble Financial maintains Syntel, Inc. (Nasdaq: SYNT) at Buy with a price target of $112 following Q3 results reported earlier this week.

Analyst Vincent Colicchio noted the following key points:

Reported third quarter 2014 EPS of $1.47, which exceeded our forecast and street consensus... More

Syntel, Inc. (SYNT) Tops Q3 EPS by 8c; Boosts FY14 EPS Outlook

October 16, 2014 8:31 AM EDT

Syntel, Inc. (NASDAQ: SYNT) reported Q3 EPS of $1.47, $0.08 better than the analyst estimate of $1.39. Revenue for the quarter came in at $228.3 million versus the consensus estimate of $236.96 million.

Syntel, Inc. sees FY2014 EPS of $5.60-$5.70, versus prior guidance of $5.5-$5.65 and the consensus of... More